Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: Prodigiosin vs. obatoclaxMargarita Espona‐Fiedler, Ricardo Pérez‐Tomás, A. Hosseini et al.|Biochemical Pharmacology|2011Cited by 74